InsiderCluster

ALHC

NasdaqGS

Alignment Healthcare, Inc.

$14.85
-3.76 (-20.20%)

Price

-0.37% over 1D

Key statistics

Previous close$18.61
Day range13.14 – 16.49
52-week range12.97 – 25.12
Volume17.48M
CurrencyUSD
ExchangeNasdaqGS
Crowd sentiment
100Bullish

Insider activity

SEC EDGAR ↗
Open-mkt buys
0
$0.00
Open-mkt sells
11
$19,224,344.13
Net flow
19.22M
11 open-market trades

Showing 14 recent filings. 3 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.

InsiderTypeSharesPriceValueDate
Maroney Dawn Christine
President
Option exercise152.07K$9.06$1,377,736.082026-07-15
Maroney Dawn Christine
President
Sell (open market)177.07K$20.83$3,687,990.012026-07-15
Maroney Dawn Christine
President
Option exercise152.07K$9.06$1,377,736.082026-07-15
KAO JOHN E
Director, Chief Executive Officer
Sell (open market)279.64K$19.81$5,540,362.862026-07-10
KAO JOHN E
Director, Chief Executive Officer
Sell (open market)18.36K$20.65$378,998.172026-07-10
Hochradel Shane J.
Chief Operations Officer
Grant / award87.72K$0.002026-07-01
KONOWIECKI JOSEPH S
Director, EVP, Corporate Affairs
Sell (open market)25K$24.00$600,000.002026-07-01
KONOWIECKI JOSEPH S
Director, EVP, Corporate Affairs
Sell (open market)25K$23.00$575,000.002026-06-26
KONOWIECKI JOSEPH S
Director, EVP, Corporate Affairs
Sell (open market)25K$22.00$550,000.002026-06-18
Maroney Dawn Christine
President
Sell (open market)30K$19.55$586,425.002026-06-15
Kim Hyong
Chief Medical Officer
Sell (open market)35.95K$19.86$713,947.312026-06-12
KONOWIECKI JOSEPH S
Director, EVP, Corporate Affairs
Sell (open market)25K$21.00$525,000.002026-06-11
KAO JOHN E
Director, Chief Executive Officer
Sell (open market)74.94K$19.65$1,472,350.022026-06-10
KAO JOHN E
Director, Chief Executive Officer
Sell (open market)223.06K$20.60$4,594,270.762026-06-10

Source: SEC EDGAR Forms 4/4A (CIK 1832466). Click an insider to open the original filing.

Social sentiment

100
Bullish

Volume-weighted across live social sources

StockTwitsLIVE
2 bull1000 bear
Recent posts
@VizionaryPix· StockTwits2d ago

$CLOV member growth is going to be massive next year. Who thinks it’s priced in? A year or 2 behind $ALHC Only thing to analyze before Counterpart takes the drivers seat

@capntrps· StockTwits2d ago

$ALHC certainly like this stock. I think i need to discuss what would happen when government programs change policy to determine the potential structural/existential risks. Othereise interesting entry.

@ajwu· StockTwits2d ago

$CLOV is down with this $ALHC garbage stock again

@GetVector· StockTwits2d ago

Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $ALHC, $AXTI, $RBLX, $RDDT.

@OpenOutcrier· StockTwits2d ago

$ALHC (-15.6% pre) Alignment Healthcare LLC earnings beat by $0.04, revenue fell short of estimates https://ooc.bz/l/109459

@CallYourMommy· StockTwits3d ago

$CLOV - $ALHC 👨🏽‍🍳 📕 and the stock still 📈 🚀

@Conrad_Weiner· StockTwits3d ago

$ALHC sold all my alhc and bought $CLOV

@Grumpy_Cat· StockTwits3d ago

$CLOV $ALHC FCF flipped negative. That’s why stock is taking a shit

@YorkyChaos· StockTwits3d ago

$CLOV $ALHC My interpretation The quarter itself appears strong: very high membership growth; solid MBR; substantial adjusted EBITDA growth; continued GAAP profitability; guidance floors raised. But the report may be disappointing relative to expectations because: Revenue was close to consensus, rather than a large beat. The EBITDA guidance ceiling remained at $163M. Only $3.5M was added to the FY EBITDA midpoint despite a roughly $13M Q2 beat versus prior midpoint guidance. The implied H2 EBITDA outlook fell by approximately $9.6M. Management is apparently preserving substantial room for H2 medical-cost seasonality and investment spending. The stock’s valuation required a cleaner beat-and-raise result. So the correct characterization is not “bad earnings.” It is closer to: Excellent backward-looking Q2 results, but a surprisingly cautious forward profitability outlook. That forward-guidance disconnect is exactly the kind of issue generic AI earnings summaries frequently fail to identify.

@raiders9999· StockTwits3d ago

$ALHC

@CallYourMommy· StockTwits3d ago

$CLOV - $ALHC didn't get a trophy from cms this week

@tartanblaster· StockTwits3d ago

$CLOV what on earth is going on with AH reaction to $ALHC earnings? Look good to me...

Latest news

Get insider-buy alerts

Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.